Zobrazeno 1 - 10
of 45
pro vyhledávání: '"S. D. Baker"'
Autor:
J. Gartrell, J. C. Panetta, S. D. Baker, Y. L. Chen, D. S. Hawkins, A. Ostrenga, T. J. Scharschmidt, S. L. Spunt, D. Wang, A. R. Weiss
Publikováno v:
Cancer Chemother Pharmacol
PURPOSE: The use of tyrosine kinase inhibitors for the treatment for soft tissue sarcomas is increasing given promising signals of activity in a variety of tumor types. The recently completed study in non-rhabdomyosarcoma soft tissue sarcomas, ARST13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4976171463bb4c468c53b7a3897a687
https://europepmc.org/articles/PMC8958317/
https://europepmc.org/articles/PMC8958317/
Autor:
S. D. Baker, Maria S. Sepúlveda
Publikováno v:
Ecotoxicology. 18:271-280
Contaminants in Great Blue Herons (Ardea herodias) from Indiana were quantified to determine if levels were high enough to impair reproduction. During 2005 and 2006, 35 eggs were collected from 6 colonies and analyzed for contaminants. Between 30 and
Autor:
S. D Baker
Publikováno v:
AACR Education book. 2008:705-709
Autor:
T. A. Klein, Rodney A. Hill, R. A. Battaglia, D. G. Falk, S. D. Baker, J. C. Miller, J.B. Glaze, J. I. Szasz, P. S. Kuber, R. Richard, Carl W. Hunt
Publikováno v:
Journal of Animal Science. 84:938-945
Relationships between residual feed intake (RFI) and other performance variables were determined using 54 purebred Angus steers. Individual feed intake and BW gain were recorded during a 70-d post-weaning period to calculate RFI. After the 70-d post-
Publikováno v:
Journal of Clinical Oncology, 22(14), 739S-739S. American Society of Clinical Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de9e53c59490e24340cf8def2213e93a
https://pure.eur.nl/en/publications/e242fee7-84e0-4b05-b532-1f991690340a
https://pure.eur.nl/en/publications/e242fee7-84e0-4b05-b532-1f991690340a
Autor:
M O, Bradley, N L, Webb, F H, Anthony, P, Devanesan, P A, Witman, S, Hemamalini, M C, Chander, S D, Baker, L, He, S B, Horwitz, C S, Swindell
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(10)
Certain natural fatty acids are taken up avidly by tumors for use as biochemical precursors and energy sources. We tested in mice the hypothesis that the conjugation of docosahexaenoic acid (DHA), a natural fatty acid, and an anticancer drug would cr
Publikováno v:
SAE Technical Paper Series.
Autor:
J, Gilbert, S D, Baker, M K, Bowling, L, Grochow, W D, Figg, Y, Zabelina, R C, Donehower, M A, Carducci
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(8)
Phenylbutyrate (PB) is an aromatic fatty acid with multiple mechanisms of action including histone deacetylase inhibition. Preclinically, PB demonstrates both cytotoxic and differentiating effects at a concentration of 0.5 mM. We conducted a Phase I
Autor:
C D, Britten, S D, Baker, L J, Denis, T, Johnson, R, Drengler, L L, Siu, K, Duchin, J, Kuhn, E K, Rowinsky
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(9)
Oral paclitaxel is not inherently bioavailable because of the overexpression of P-glycoprotein by intestinal cells and the significant first-pass extraction by cytochrome P450-dependent processes. This study sought to simulate the toxicological and p
Autor:
C D, Britten, E K, Rowinsky, S D, Baker, G R, Weiss, L, Smith, J, Stephenson, M, Rothenberg, L, Smetzer, J, Cramer, W, Collins, D D, Von Hoff, S G, Eckhardt
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(1)
This Phase I study was performed to evaluate the tolerability and pharmacokinetic behavior of MKT-077, a water soluble rhodacyanine dye analogue, which partitions into tumor cell mitochondria where it is thought to act as a metabolic poison, leading